NICOLA HANANIA to Muscarinic Antagonists
This is a "connection" page, showing publications NICOLA HANANIA has written about Muscarinic Antagonists.
Connection Strength
2.438
-
Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgrad Med. 2017 Jun; 129(5):500-512.
Score: 0.560
-
Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Rev Respir Med. 2016 07; 10(7):767-80.
Score: 0.527
-
Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421.
Score: 0.221
-
Management of Life-Threatening Asthma: Severe Asthma Series. Chest. 2022 10; 162(4):747-756.
Score: 0.196
-
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. Int J Chron Obstruct Pulmon Dis. 2021; 16:865-875.
Score: 0.184
-
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. Int J Chron Obstruct Pulmon Dis. 2018; 13:2805-2819.
Score: 0.154
-
Clinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2019 01; 155(1):168-177.
Score: 0.153
-
Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension? Delivery Technology in patients with chronic obstructive pulmonary disease. Respir Med. 2017 05; 126:105-115.
Score: 0.139
-
New bronchodilators. Curr Opin Pharmacol. 2012 Jun; 12(3):238-45.
Score: 0.098
-
The COPD Pipeline XII. COPD. 2011 Oct; 8(5):387-91.
Score: 0.095
-
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023. Lung. 2024 04; 202(2):119-125.
Score: 0.056
-
Revisiting asthma pharmacotherapy: where do we stand and where do we want to go? Eur Respir J. 2023 08; 62(2).
Score: 0.054